Shareholding disclosure

BB Medtech AG

Declared position

12.3%

Threshold

Crossed upwards

Timeline

Published

24.06.2002

Transaction

—

Voting rights breakdown

Voting rights acquired12.3%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T1618D1590

Beneficial owner

BB Medtech AG

Declared address

BB Medtech AG, Schaffhausen

24.06.2002; Kotierungsprospekt

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

BB Medtech AG

Nobel Biocare Holding AG24.06.2002T1618D1590

Disclosure summary

BB Medtech AG disclosed a holding in Nobel Biocare Holding AG on the acquisition side, published by SIX Exchange Regulation on 24.06.2002, at 12.3% of voting rights. Notice category: Group of shareholders.

Disclosed position

12.3%

Voting rights acquired

Voting rights acquired12.3%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

BB Medtech AG disclosed a holding in Nobel Biocare Holding AG, published on 24.06.2002.

Publication date24.06.2002

Issuing companyNobel Biocare Holding AG

Beneficial ownerBB Medtech AG

Declared addressBB Medtech AG, Schaffhausen

CategoryGroup of shareholders

Voting rights acquired12.3%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT1618D1590

Commercial register

CHE-103.445.652

Struck off the register · 04.05.2010

Zefix record

Conditions

24.06.2002; Kotierungsprospekt

Source: SIX Exchange Regulation · Publication date: 24.06.2002

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open